Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $19,861 | 6 | 85.1% |
| Travel and Lodging | $2,976 | 9 | 12.7% |
| Food and Beverage | $511.45 | 13 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $21,471 | 24 | $0 (2024) |
| ViiV Healthcare Company | $1,840 | 2 | $0 (2019) |
| AbbVie Inc. | $37.22 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,860 | 1 | Merck Sharp & Dohme LLC ($1,860) |
| 2021 | $3,873 | 3 | Merck Sharp & Dohme LLC ($3,836) |
| 2019 | $17,580 | 23 | Merck Sharp & Dohme Corporation ($15,740) |
| 2018 | $35.11 | 1 | Merck Sharp & Dohme Corporation ($35.11) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/06/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,860.00 | General |
| 12/08/2021 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $3,836.25 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/08/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2019 | Merck Sharp & Dohme Corporation | DELSTRIGO (Drug) | Consulting Fee | Cash or cash equivalent | $7,650.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/18/2019 | Merck Sharp & Dohme Corporation | DELSTRIGO (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/18/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $48.79 | General |
| 09/18/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $14.94 | General |
| 09/17/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $243.10 | General |
| 09/17/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 09/17/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $44.81 | General |
| 09/17/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $29.89 | General |
| 09/16/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $1,217.61 | General |
| 09/16/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $243.10 | General |
| 09/16/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $65.53 | General |
| 07/19/2019 | ViiV Healthcare Company | — | Consulting Fee | Cash or cash equivalent | $920.00 | General |
| 07/19/2019 | ViiV Healthcare Company | — | Consulting Fee | Cash or cash equivalent | $920.00 | General |
| 05/02/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $26.63 | General |
| 04/05/2019 | Merck Sharp & Dohme Corporation | MK-8591A (Drug) | Consulting Fee | Cash or cash equivalent | $4,675.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/05/2019 | Merck Sharp & Dohme Corporation | MK-8591A (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/19/2019 | Merck Sharp & Dohme Corporation | MK-8591 (Drug) | Travel and Lodging | In-kind items and services | $193.72 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/19/2019 | Merck Sharp & Dohme Corporation | MK-8591 (Drug) | Travel and Lodging | In-kind items and services | $118.39 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/19/2019 | Merck Sharp & Dohme Corporation | MK-8591 (Drug) | Food and Beverage | In-kind items and services | $64.49 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/19/2019 | Merck Sharp & Dohme Corporation | MK-8591 (Drug) | Food and Beverage | In-kind items and services | $53.74 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/19/2019 | Merck Sharp & Dohme Corporation | MK-8591 (Drug) | Food and Beverage | In-kind items and services | $40.30 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 47 | 66 | $49,250 | $6,328 |
| 2020 | 2 | 30 | 48 | $27,365 | $5,498 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 17 | $22,440 | $2,870 | 12.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 31 | $14,570 | $1,884 | 12.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 18 | $12,240 | $1,573 | 12.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 17 | 35 | $15,925 | $3,172 | 19.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 13 | 13 | $11,440 | $2,326 | 20.3% |
About Dr. Judith Currier, MD
Dr. Judith Currier, MD is a Infectious Disease healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508882614.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Judith Currier, MD has received a total of $23,349 in payments from pharmaceutical and medical device companies, with $1,860 received in 2024. These payments were reported across 28 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($19,861).
As a Medicare-enrolled provider, Currier has provided services to 77 Medicare beneficiaries, totaling 114 services with total Medicare billing of $11,826. Data is available for 2 years (2020–2022), covering 5 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Location Los Angeles, CA
- Active Since 07/14/2006
- Last Updated 06/09/2010
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1508882614
Products in Payments
- DELSTRIGO (Drug) $7,800
- MK-8591A (Drug) $4,825
- MK-8591 (Drug) $1,131
- UBRELVY (Drug) $37.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Los Angeles
Peter Ruane, Md, MD
Infectious Disease — Payments: $866,043
Dr. Jay Gladstein, M.d, M.D
Infectious Disease — Payments: $732,232
Otto Yang, Md, MD
Infectious Disease — Payments: $477,960
Irving Posalski, M.d, M.D
Infectious Disease — Payments: $235,663
Dr. Fred Sattler, M.d, M.D
Infectious Disease — Payments: $69,230
Dr. Shaker Itani, M.d, M.D
Infectious Disease — Payments: $51,940